Navigation Links
Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice
Date:3/4/2008

BOSTON, March 4 /PRNewswire-USNewswire/ -- A Fairport, New York man was charged today in federal court with obstruction of justice.

United States Attorney Michael J. Sullivan; Warren T. Bamford, Special Agent in Charge of the Federal Bureau of Investigation in New England; Joseph C. Moraski, Special Agent in Charge of the Department of Health and Human Services Office of Inspector General; Keith A. Johnston, Resident Agent in Charge of the Defense Criminal Investigative Service; Mark Dragonetti, Resident Agent in Charge of the Criminal Investigative Service of the Food and Drug Administration; Jeffrey Hughes, Special Agent in Charge of the Veterans Administration Office of Inspector General and Randy Miskanci, Postal Inspector in Charge of the United States Postal Service Office of Inspector General announced today that THOMAS FARINA, age 41, of Fairport, New York, was charged in a four count indictment with obstruction of justice.

The indictment alleges that in the summer of 2004, FARINA, then a manager for a pharmaceutical company, altered and deleted documents from his own computer and directed sales representatives under his management to alter or delete from their computers documents that reflected the off-label promotion of a drug, at a time when they knew that their employer, was under investigation for promoting that drug for unapproved uses, and at a time when they had been specifically instructed to preserve all such documents relating to the promotion of that drug. The indictment specifically alleges as follows,

(1) Prior to the summer of 2004, FARINA had directed sales representatives to promote a drug for uses and at dosages that had specifically been denied approval by the Food and Drug Administration. The grounds for the FDA's non-approval had included safety concerns about the drug's use in those contexts and at the higher dosages.

(2) In early 2004, the pharmaceutical company and FARINA and these sales repr
'/>"/>

SOURCE U.S. Attorney's Office
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
4. MDS to Present at Thomas Weisel Partners Healthcare Conference
5. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Mediware Names Thomas K. Mann Chief Executive Officer
8. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
9. Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
10. Canary Foundation and the Thomas G. Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative
11. American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...search has proved that a new drug named histatin, ...ills the fungus- Candida albicans,// which is resp...s known that candidiasis, also known as thrush, is...ts and ulcers on the membranes of the mouth, tongu...
...udies on vitamin E seemed to suggest that suppleme...cancer and heart problems. //Recently, a study pub... says the reality of taking vitamin E supplements ...searchers had studied patients with cardiovascular...
...ur kind of immunity may lead you to blindness. Acc...ience journal, //scientists had been able to find ...ight. In search of what is commonly known as blin... up with a gene that may cause macular degeneratio...
... has been shown that the drug Rimonabant (Acompli... can help obese patients keep weight off // . Supp... resulted in a significant decrease in body weight...cularly dangerous visceral fat. It also improved H...
Other Medicine News:
(Date:10/7/2008)...wire/ -- Prometheus Laboratories Inc., a,specialty...from its,development of PROMETHEUS(R) IBS Diagnost...wel syndrome (IBS). The findings suggest measurabl...arkers in blood samples,between IBS and non-IBS pa...mbined with a proprietary algorithm, led to the de...
(Date:10/7/2008)...Newswire/ -- The Texas Cardiac Arrhythmia,Institut...lected as one of,only a few sites in the nation to... a new device to treat persistent atrial fibrillat...d research center specializing in heart,rhythm dis...al Center and,Texas Cardiovascular Consultants., ...
(Date:10/7/2008)...tate Prevented Immunologic Changes Induced by ..., Additional Data Indicates Potential in Treating ... /- Alba Therapeutics Corporation,pre... at the American,College of Gastroenterology (ACG)...LIN 1001-004, the first Phase IIa trial conducted ...
(Date:10/7/2008)... 7 /- A study published in the,scient...self-renewal,reported that InVitria,s ( http://ww...m albumin) was an effective replacement to bovine ...titled, "The ground state of embryonic stem cell,s...astim as a recombinant,albumin in place of animal-...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Male Partner Violence Hurts Womens Health Worldwide 15952 1Male Partner Violence Hurts Womens Health Worldwide 15952 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 1Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 3PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 1PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 2IPC The Hospitalist Company Added to Russell 2000 Index 15946 1IPC The Hospitalist Company Added to Russell 2000 Index 15946 2
...o., March 06, 2007 /PRNewswire-FirstCall/ --,Repli...ts Phase II,clinical trial using faropenem medoxom...itis media (AOM), a common infection of the,middle...hat it met,its primary objective to show that faro...the middle ear and to permit the dose,selection fo...
...., March 06, 2007 /PRNewswire-FirstCall/ --,Advanc...completed,Phase III multi- center clinical studies... therapeutic will be presented during,the National...ings,taking place April 10th through 14th in Orlan...cheduled to be presented on,Wednesday, April 11, 2...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4
Lamellar Blade tip 6600 style, angled bevel up. Dimensions: 11.0 mm (L) x 2.4 mm (W). Cut: 3.7 mm.
19 g MVR knife. Dimensions: 31.8 mm x 1.45 mm x 3.3 mm.
Full Handle Laseredge Slit Blade Knife, 3.2 mm angled double bevel. Blade tip dimension: 14.4 mm x 3.2 mm x 4.0 mm.
Full Handle Laseredge Slit Blade Knife, 3.0 mm straight. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm.
Medicine Products: